Keywords: Roche, Avastin, Glioblastoma, Newly-diagnosed, Ph III, AVAglio study

Roche's Avastin effective in people with newly-diagnosed glioblastoma

Article | 20 November 2012

Print This

Adding Swiss drug major Roche's (ROG: SIX) blockbuster cancer drug Avastin (bevacizumab) to the current standard of care for newly-diagnosed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in